Middle East & Africa Preclinical Cro Market Size & Outlook

The preclinical cro market in Middle East & Africa is expected to reach a projected revenue of US$ 126.4 million by 2033. A compound annual growth rate of 5.9% is expected of Middle East & Africa preclinical cro market from 2026 to 2033.
Revenue, 2025 (US$M)
$78.7
Forecast, 2033 (US$M)
$126.4
CAGR, 2026 - 2033
5.9%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa preclinical cro market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA preclinical cro market highlights

  • The MEA preclinical cro market generated a revenue of USD 78.7 million in 2025.
  • The market is expected to grow at a CAGR of 5.9% from 2026 to 2033.
  • In terms of segment, preclinical optimization, efficacy & pk/pd was the largest revenue generating development stage in 2025.
  • Early CMC / Phase I–II Supply is the most lucrative development stage segment registering the fastest growth during the forecast period.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2026 to 2033.


MEA data book summary

Market revenue in 2025USD 78.7 million
Market revenue in 2033USD 126.4 million
Growth rate5.9% (CAGR from 2026 to 2033)
Largest segmentPreclinical optimization, efficacy & pk/pd
Fastest growing segmentEarly CMC / Phase I–II Supply
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTarget Discovery, Preclinical Optimization, Efficacy & PK/PD, IND-Enabling Safety (GLP), Bioanalysis & Analytics, Early CMC / Phase I–II Supply
Key market players worldwideEurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.2% of the global preclinical cro market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,290.3 million by 2033.

Preclinical optimization, efficacy & pk/pd was the largest segment with a revenue share of 39.14% in 2025. Horizon Databook has segmented the Middle East & Africa preclinical cro market based on target discovery, preclinical optimization, efficacy & pk/pd, ind-enabling safety (glp), bioanalysis & analytics, early cmc / phase i–ii supply covering the revenue growth of each sub-segment from 2021 to 2033.


A growing population and favorable government initiatives to increase access to healthcare are expected to attract global biopharmaceutical and medical companies to enter this market. As an increasing number of biopharmaceutical and medical device companies are outsourcing their R&D services in the region, the number of clinical trials is expected to grow.

An increasing number of R&D projects & CROs and the growing number of pharmaceutical & biotechnology companies in the region are expected to boost market growth during the forecast period. The country is adopting global standards and collaborating with other global CROs to mark its market presence.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Preclinical CRO Market Companies

Name Profile # Employees HQ Website
SGA View profile 11-50 Las Condes, Region Metropolitana, Chile, South America https://sgasa.cl
Crown Bioscience View profile 251-500 Santa Clara, California, United States, North America http://www.crownbio.com
Intertek Group PLC View profile 44000 33 Cavendish Square, London, United Kingdom, W1G 0PS https://www.intertek.com
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

MEA preclinical cro market size, by country, 2021-2033 (US$M)

Middle East & Africa Preclinical CRO Market Outlook Share, 2025 & 2033 (US$M)

MEA preclinical cro market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online